A Phase 2 Study of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients With Crohn’s Disease
- Resource Type
- Article
- Authors
- Vermeire, Severine A.R.A.; Dewit, Olivier; Peeters, Harald; Stehlik, Jiri; Vanasek, Tomas; Laharie, David; Colombel, Jean Frederic; Bigard, Marc-André; Varga, Marta; Zeher, Margit; Novak, Janos; Hunyady, Bela; Salamon, Agnes; Racz, Istvan; Gionchetti, Paolo; Kohn, Anna; Prantera, Cosimo; Stokkers, P.C.F.; Slomka, Maria; Paradowski, Leszek; Arlukowicz, Tomasz; Kuzela, Ladislav; Baricky, Boris; Hlavaty, Tibor; Vera, Maria Isabel; Panes, Julian; Guardiola, Jordi; Probert, Christopher; Shaffer, Jonathan Lionel; Fleisher, Mark; Pruitt, Ronald Edward; Sandborn, William J.; Goff, John Sawyer; Weber, John; Bell, Raymond Lloyd; Zwick, Andrew Harrison; Gutierrez, Alexandra; Levine, Robert H.; Hanauer, Stephen Brett; Lavelle, Lori Ann; Kottoor, Ravindranath K.; Dryden, Gerald Wayne, Jr.; Hardi, Robert; Glorioso, David Vaughn; Swaroop, Prabhakar; Lee, Scott D.; Patrick, Teressa Joan; Scheinert, Sheldon; Sninsky, Charles A.; Katz, Seymour; Noar, Mark D.; Gaspari, Michael Marion; Gordon, Glenn L.; Dalton, Thomas A.; Homoky, Douglas Edward; Kilgore, William Ransom, III; Levien, Joel A.; Schneider, Herbert R.; Moola, Suleman Abdul; Kruger, Frederik Cornelius; Wright, John P.; Aboo, Nazimuddin; Ghosh, Subrata; Vranic, Ivana; Wang, Wenjin; Niezychowski, Wojciech
- Source
- In Clinical Gastroenterology and Hepatology September 2014 12(9):1485-1493
- Subject
- Language
- ISSN
- 1542-3565